MIBio: A Huge Success for RedShiftBio

A major theme at MiBio 2019 focused on strategies to address challenges in protein-protein interactions, formulation, drug product development and competitive product profiles. Conversations quickly honed in around the increasing reliance on microfluidic modulation spectroscopy to obtain insights into structural changes in proteins during biopharmaceutical product development. The technology is quickly becoming the go-to solution in biophysical characterization specialists’ toolbox, replacing legacy techniques such as FTIR and CD. It is exciting to see the response of the European biopharmaceutical industry to our technology.